Evidence map›Paper›PMID 20466874›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2010

Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule.

Ming Chang Hu, Mingjun Shi, Jianning Zhang, Johanne Pastor, Teruyo Nakatani, Beate Lanske, M Shawkat Razzaque, Kevin P Rosenblatt, Michel G Baum, Makoto Kuro-o and 1 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 291 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
291citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

291 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.Journal of the American Society of Nephrology : JASN · 2018
    Pooled it
  4. Correlation between SolubleBioMed research international · 2018
    Pooled it
  5. Trial
  6. A Controlled Increase in Dietary Phosphate Elevates BP in Healthy Human Subjects.Journal of the American Society of Nephrology : JASN · 2018
    Trial
  7. Trial
  8. Trial
  9. Klotho revisited: tubular heterogeneity reshapes mineral metabolism, aging, and CKD.Pflugers Archiv : European journal of physiology · 2026
    Review
  10. Article
  11. Review
  12. Integrative Approaches to Treating Cellular Senescence in Kidney Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

231 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ming Chang HuDepartment of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390-8885, USA.
Mingjun Shi
Jianning Zhang
Johanne Pastor
Teruyo Nakatani
Beate Lanske
M Shawkat Razzaque
Kevin P Rosenblatt
Michel G Baum
Makoto Kuro-o
Orson W Moe

Funding

UT Southwestern O'Brien Kidney Research Core CenterP30DK079328 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MOE, ORSON W · 2007 to 2021
$16.9M
RENAL BASIS OF HYPOCITRATURIAP01DK020543 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI HUANG, CHOU-LONG · 1986 to 2008
$12.7M
Effects of Klotho Protein on Aging and MetabolismR01AG019712 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI KURO-O, MAKOTO · 2002 to 2011
$4.1M
Tissue-specific Mechanism of Action of the Metabolic Hormones FGF19 and FGF21R01DK067158 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI KLIEWER, STEVEN A. · 2004 to 2017
$4.1M
Neonatal Proximal Tubule AcidificationR01DK041612 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI BAUM, MICHEL GERARD, MOE, ORSON W · 1991 to 2013
$2.7M
Proteomics of mouse models for aging and longevityR01AG025326 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI KURO-O, MAKOTO · 2004 to 2008
$1.5M
Acute Regulation of the Renal Na/H Exchanger NHE-3R01DK048482 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI MOE, ORSON W · 2001 to 2005
$1.3M
REGULATION OF RENAL NA+/H+ EXCHANGER BY PROTEIN KINASE AR29DK048482 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI MOE, ORSON W · 1995 to 1999
–
NIA NIH HHS AG19712NIA NIH HHS AG25326NIA NIH HHS R01 AG019712NIA NIH HHS R01 AG025326NIDDK NIH HHS DK067158NIDDK NIH HHS DK-20543NIDDK NIH HHS DK41612NIDDK NIH HHS DK-48482NIDDK NIH HHS P01 DK020543NIDDK NIH HHS P30 DK079328NIDDK NIH HHS P30-DK-079328NIDDK NIH HHS R01 DK041612NIDDK NIH HHS R01 DK048482NIDDK NIH HHS R01 DK067158NIDDK NIH HHS R29 DK048482
6 · The paper itself

Abstract

Klotho has profound effects on phosphate metabolism, but the mechanisms of how Klotho affects phosphate homeostasis is unknown. We detected Klotho in the proximal tubule cell, brush border, and urinary lumen, where phosphate homeostasis resides. Increasing Klotho in the kidney and urine chronically by transgenic overexpression or acutely by intravenous infusion caused hypophosphatemia, phosphaturia from decreased proximal phosphate reabsorption, and decreased activity and protein of the principal renal phosphate transporter NaPi-2a. The phosphaturic effect was present in FGF23-null mice, indicating a direct action distinct from Klotho's known role as a coreceptor for FGF23. Direct inhibition of NaPi-2a by Klotho was confirmed in cultured cells and in cell-free membrane vesicles characterized by acute inhibition of transport activity followed by decreased cell surface protein. Transport inhibition can be mimicked by recombinant beta-glucuronidase and is associated with proteolytic degradation and reduced surface NaPi-2a. The inhibitory effect of Klotho on NaPi-2a was blocked by beta-glucuronidase inhibitor but not by protease inhibitor. Klotho is a novel phosphaturic substance that acts as an enzyme in the proximal tubule urinary lumen by modifying glycans, which cause decreased transporter activity, followed by proteolytic degradation and possibly internalization of NaPi-2a from the apical membrane.

Indexed as

AnimalsCells, CulturedFibroblast Growth Factor-23GlucuronidaseGlycoproteinsHomeostasisHypophosphatemia, FamilialImmunoblottingImmunohistochemistryKidney TubulesKlotho ProteinsMiceMice, TransgenicMicroscopy, FluorescenceMicroscopy, ImmunoelectronMicrovillibeta-glucuronidase inhibitorFgf23 protein, mouseFibroblast Growth Factor-23GlucuronidaseGlycoproteinsKlotho ProteinsPhosphatesProtease InhibitorsSodium-Phosphate Cotransporter Proteins, Type IIa

Identifiers

PMID20466874
PMCPMC2923354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.